PureTech Health is a

biotechnology Biotechnology is the integration of natural sciences and engineering sciences in order to achieve the application of organisms, cells, parts thereof and molecular analogues for products and services. The term ''biotechnology'' was first used b ...

company which develops medicines to combat serious diseases. It is listed on the

London Stock Exchange London Stock Exchange (LSE) is a stock exchange in the City of London, England, United Kingdom. , the total market value of all companies trading on LSE was £3.9 trillion. Its current premises are situated in Paternoster Square close to St Pa ...

and is a constituent of the

FTSE 250 Index The FTSE 250 Index ( "Footsie") is a capitalisation-weighted index consisting of the 101st to the 350th largest companies listed on the London Stock Exchange. Promotions and demotions to and from the index occur quarterly in March, June, Septemb ...

History

The company was founded by

Daphne Zohar Daphne Zohar (born sometime after 1968) is an American entrepreneur. She is the founder and CEO of PureTech Health, a biotechnology firm. PureTech went public in June 2015 and is a FTSE250 company. She was named to the MIT Technology Review T ...

, an American entrepreneur, in 2005. It was the subject of an

initial public offering An initial public offering (IPO) or stock launch is a public offering in which shares of a company are sold to institutional investors and usually also to retail (individual) investors. An IPO is typically underwritten by one or more investme ...

on the

in June 2015.

Operations

Companies which PureTech Health founded include Karuna Pharmaceuticals, Gelesis, which has received FDA approval as a treatment for weight management, Akili Interactive Labs, which is developing a digital therapeutic platform for cognitive disorders, Vedanta Biosciences, which is developing drugs to treat autoimmune and inflammatory diseases, and Follica which is developing new treatments for androgentic alopecia among others. PureTech also has a pipeline of its own immunology, lymphatic and oncology based therapeutics.

References

External links

* {{FTSE 250 Index constituents Health care companies of the United Kingdom Health care companies established in 2001 2001 establishments in the United Kingdom Companies listed on the London Stock Exchange